Literature DB >> 26252454

Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis.

Arman Jahangiri1, Jeffrey R Wagner1, Sung Won Han1, Mai T Tran1, Liane M Miller1, Rebecca Chen1, Maxwell W Tom1, Lauren R Ostling1, Sandeep Kunwar1, Lewis Blevins1, Manish K Aghi1.   

Abstract

OBJECTIVE: The impact of transsphenoidal surgery for nonfunctional pituitary adenomas (NFAs) on preoperative hypopituitarism relative to the incidence of new postoperative endocrine deficits remains unclear. The authors investigated rates of hypopituitarism resolution and development after transsphenoidal surgery.
METHODS: Over a 5-year period, 305 transsphenoidal surgeries for NFAs performed at The California Center for Pituitary Disorders were retrospectively reviewed.
RESULTS: Patients with preoperative endocrine deficits (n = 153, 50%) were significantly older (mean age 60 vs 54 years; p = 0.004), more frequently male (65% vs 44%; p = 0.0005), and had larger adenomas (2.4 cm vs 2.1 cm; p = 0.02) than patients without preoperative deficits (n = 152, 50%). Of patients with preoperative endocrine deficits, 53% exhibited symptoms. Preoperative deficit rates were 26% for the thyroid axis; 20% and 16% for the male and female reproductive axes, respectively; 13% for the adrenocorticotropic hormone (ACTH)/cortisol axis, and 19% for the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis. Laboratory normalization rates 6 weeks and 6 months after surgery without hormone replacement were 26% and 36% for male and 13% and 13% for female reproductive axes, respectively; 30% and 49% for the thyroid axis; 3% and 3% for the cortisol axis; and 9% and 22% for the IGF-1 axis (p < 0.05). New postoperative endocrine deficits occurred in 42 patients (13.7%). Rates of new deficits by axes were: male reproductive 3% (n = 9), female reproductive 1% (n = 4), thyroid axis 3% (n = 10), cortisol axis 6% (n = 19), and GH/IGF-1 axis 4% (n = 12). Patients who failed to exhibit any endocrine normalization had lower preoperative gland volumes than those who did not (0.24 cm(3) vs 0.43 cm(3), respectively; p < 0.05). Multivariate analyses revealed that no variables predicted new postoperative deficits or normalization of the female reproductive, cortisol, and IGF-1 axes. However, increased preoperative gland volume and younger age predicted the chances of a patient with any preoperative deficit experiencing normalization of at least 1 axis. Younger age and less severe preoperative hormonal deficit predicted normalization of the thyroid and male reproductive axes (p < 0.05).
CONCLUSIONS: After NFA resection, endocrine normalization rates in this study varied with the hormonal axis and were greater than the incidence of new endocrine deficits. Low preoperative gland volume precluded recovery. Patient age and the severity of the deficiency influenced the recovery of the thyroid and male reproductive axes, the most commonly impaired axes and most likely to normalize postoperatively. This information can be of use in counseling patients with hypopituitarism who undergo NFA surgery.

Entities:  

Keywords:  ACTH = adrenocorticotropic hormone; FSH = follicle-stimulating hormone; GH = growth hormone; GnRH = gonadotropin-releasing hormone; IGF-1= insulin-like growth factor-1; LH = luteinizing hormone; NFA = nonfunctional adenoma; T4 = thyroxine; TRH = thyrotropin-releasing hormone; TSH = thyroid-stimulating hormone; endocrine deficits; hypopituitarism; nonfunctional adenoma; pituitary surgery

Mesh:

Year:  2015        PMID: 26252454     DOI: 10.3171/2015.1.JNS141543

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  26 in total

1.  Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomas.

Authors:  Orsalia Alexopoulou; Valérie Everard; Martine Etoa; Edward Fomekong; Stéphane Gaillard; Fabrice Parker; Christian Raftopoulos; Philippe Chanson; Dominique Maiter
Journal:  Endocrine       Date:  2021-04-14       Impact factor: 3.633

Review 2.  Guidelines in the management of CNS tumors.

Authors:  Navid Redjal; Andrew S Venteicher; Danielle Dang; Andrew Sloan; Remi A Kessler; Rebecca R Baron; Constantinos G Hadjipanayis; Clark C Chen; Mateo Ziu; Jeffrey J Olson; Brian V Nahed
Journal:  J Neurooncol       Date:  2021-02-21       Impact factor: 4.130

3.  Intraoperative unfolding and postoperative pruning of the pituitary gland after transsphenoidal surgery for pituitary adenoma: A volumetric and endocrinological evaluation.

Authors:  Victor E Staartjes; Sarah Stricker; Giovanni Muscas; Nicolai Maldaner; David Holzmann; Jan-Karl Burkhardt; Burkhardt Seifert; Christoph Schmid; Carlo Serra; Luca Regli
Journal:  Endocrine       Date:  2018-09-21       Impact factor: 3.633

4.  Clinical characteristics and thyroid hormone dynamics of thyrotropin-secreting pituitary adenomas at a single institution.

Authors:  Akira Taguchi; Yasuyuki Kinoshita; Fumiyuki Yamasaki; Kazunori Arita; Atsushi Tominaga
Journal:  Endocrine       Date:  2020-12-07       Impact factor: 3.633

5.  Pituitary adenomas in elderly patients: clinical and surgical outcome analysis in a large series.

Authors:  Alfio Spina; Marco Losa; Pietro Mortini
Journal:  Endocrine       Date:  2019-06-17       Impact factor: 3.633

6.  Gamma Knife radiosurgery as the initial treatment for elderly patients with nonfunctioning pituitary adenomas.

Authors:  Lifeng Zhang; Wei Chen; Chang Ding; Yanjia Hu; Yuan Tian; Huiyang Luo; Jing Chen
Journal:  J Neurooncol       Date:  2021-02-27       Impact factor: 4.130

7.  Role of pituitary stalk and gland radiological status on endocrine function and outcome after endoscopic transsphenoidal surgery for non-functioning pituitary adenomas.

Authors:  C Vivancos Sánchez; A Palpán Flores; V Rodríguez Domínguez; A Zamarrón Pérez; C Álvarez-Escolá; C Pérez López
Journal:  Endocrine       Date:  2021-04-20       Impact factor: 3.633

8.  Non-functioning pituitary macroadenomas: factors affecting postoperative recurrence, and pre- and post-surgical endocrine and visual function.

Authors:  Venkatram Subramanian; Rachel Su Min Lee; Simon Howell; Samuel Gregson; Ian M Lahart; Kalpana Kaushal; Joseph M Pappachan
Journal:  Endocrine       Date:  2021-04-06       Impact factor: 3.633

9.  The impact of endoscopic transsphenoidal pituitary adenoma surgery on endocrine function: a single-centre study.

Authors:  Luke Galloway; Mohamed Ali; Andrew Lansdown; Peter Taylor; Aled Rees; John Stephen Davies; Caroline Hayhurst
Journal:  Acta Neurochir (Wien)       Date:  2020-10-21       Impact factor: 2.216

10.  Status and clinical and radiological predictive factors of presurgical anterior pituitary function in pituitary adenomas. Study of 232 patients.

Authors:  Marta Araujo-Castro; Eider Pascual-Corrales; Alberto Acitores Cancela; Sara García Duque; Luis Ley Urzaiz; Víctor Rodríguez Berrocal
Journal:  Endocrine       Date:  2020-08-12       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.